Vident Advisory, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Vident Advisory, LLC

  • $3.97 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.03 - $35.87 $146,458 - $308,482
8,600 New
8,600 $274 Million
Q3 2023

Feb 21, 2024
BUY
$12.64 - $19.76 $133,655 - $208,942
10,574 New
10,574 $135 Million
Q3 2023

Nov 14, 2023
BUY
$12.64 - $19.76 $133,655 - $208,942
10,574 New
10,574 $135 Million

Others Institutions Holding FDMT

# of Institutions
144
Shares Held
57.7M
Call Options Held
137K
Put Options Held
111K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $252M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email